RE: Well the MM's have shut is down again10 Mar 2020 10:03
Who would not want this?
"Compelling data package from two Phase II studies shows that a single dose of adjuvanted FLU-v induces cellular and antibody responses (FLU-v 003) and that it has a clinical impact in reducing disease, symptom and viral load (FLU-v 004)
RE: Not sure if this was posted yesterday10 Mar 2020 08:44
It sounds to me a dealing coming up
"But we are increasingly excited about FLU-v potentially finally entering phase III clinical trials and now is one of the most opportune times to be doing that."
FLU-v is a first-in-class 'universal', broad spectrum, standalone, influenza vaccine candidate and the results have now been published in a peer review journal
"Now we have pharma companies from around the world and particularly China knocking on our door, and I think it is sad to see these institutional investors now leave because if they just held on for a couple of months they very likely would be able to exit successfully at a much higher price..”
"I'm looking forward to working with the team in the days and weeks ahead to do our best to make the world's first Coronavirus challenge study model available as soon as possible"